Report on Our Participation at MPS World Summit 2026

From May 26 to 29, we exhibited our latest MPS products and presented a poster at the MPS World Summit 2026 in Washington D.C. Our poster featured an innovative coupling co-culture system utilizing BioStellar^™ Plate and MyoFlex^™ Plate. By linking 3D cardiac tissue with a liver model, we enabled cardiotoxicity assessment that incorporates hepatic drug metabolism. The platform’s drug low-adsorption and removable pillars address key challenges in current workflows, advancing drug discovery research. We sincerely thank everyone who visited our booth and engaged in valuable discussions.

Exhibition and Luncheon Seminar at the 53rd Annual Meeting of the Japanese Society of Toxicology

At the 53rd Annual Meeting of the Japan Society of Toxicology, held at the Grand Cube Osaka (Osaka International Convention Center), the CSAHi Safety Assessment MPS Application Team, consisting of four companies, will join forces to hold a luncheon seminar titled "The Future of Safety Assessment Opened by MPS."
In recent years, MPS technology has made groundbreaking progress in pharmaceutical development and toxicity assessment, with its range of applications expanding. In this seminar, the four companies will share the latest insights on safety assessment using MPS from their respective perspectives.
At the corporate exhibition booth (Booth No. 118), we will display the on-chip pump-type multi-organ MPS "BioStellar^™ Plate," which reproduces interactions among multiple organs to provide a more realistic biomimetic environment, as well as the "PrimeSurface^™ Series," a three-dimensional cell culture device that efficiently cultures uniform 3D cell spheroids.
Please be sure to stop by.

Cellafa Bioscience Inc. Cell Manufacturing Mr. Noriyasu Okazaki

"SUMILON^™ SuperQuality", with its high quality and stable supply system, is an indispensable presence for us at Cellafa Bioscience, who strive to automate the cell manufacturing process.
By combining the high reproducibility technology of the general-purpose humanoid robot LabDroid "Maholo" with the high-quality technology of "SUMILON^™ SuperQuality", we believe we can offer highly reliable cell-based pharmaceuticals as a Japan-originated company.